Abstract:The link between tumors and the hemostatic system, first of all platelets, has been acknowledged by numerous studies. Platelets activation at the tumor microenvironment and subsequent intravascular clotting are often associated with cancer complications. Recent clinical studies demonstrated that platelet inhibitors substantially decrease risk of tumor metastasis and mortality in cancer patients, thereby emphasizing clinical importance of platelets. However, the precise function of platelets in cancer progression remains enigmatic. Growing tumors secrete a plethora of growth factors and cytokines (tumor secretome) aiming to change its micro- and macro-environment. These factors promote angiogenesis, induce inflammation, and even stimulate changes in bones prior to metastasis. Tumor secretome signals are likely transmitted through the circulation; however, these signals need to be protected from degradation or utilization prior to reaching their target. Due to their ability to intake and secrete back a wide spectrum of proteins, platelets could function as a mobile storage compartment for the tumor secretome. Using platelet infusion and depletion during tumor growth, we assessed the role of platelets in tumor growth and tumor-induced bone remodeling. We demonstrated that platelet infusion stimulates communications between bone marrow and the tumor, while platelet depletion had the opposite effects. Importantly, tumor-induced changes in bone structure were completely abolished in the absence of platelets. Using platelets from knockout mice with various platelet defects, we demonstrated that platelet secretion (but not aggregation) was crucial for their function in tumor progression. In particular, the function of platelet α-granules is essential for the pro-tumorigenic role of platelets. Analysis of the tumor secretome revealed that 77 percent of tumor-secreted factors are highly enriched within platelets over plasma. Several of these factors are essential mediators of bone remodeling. Thus, our data show that platelet α-granule sequestration and secretion represent a cellular mechanism mediating communication between the bone microenvironment and the primary tumor.

Platelets in cancer metastasis: To help the “villain” to do evil

The critical role of platelet in cancer progression and metastasis

Platelets and circulating (tumor) cells: partners in promoting metastatic cancer

Interactions of platelets with circulating tumor cells contribute to cancer metastasis

Platelet-Leukocyte Interplay in Cancer Development and Progression

The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis

Platelets and the Tumor Cell Microenvironment

Interaction Between Circulating Cancer Cells and Platelets: Clinical Implication

Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies

The interaction of platelet-related factors with tumor cells promotes tumor metastasis

Platelets Promote Breast Cancer Cell MCF-7 Metastasis by Direct Interaction: Surface Integrin Alpha 2 Beta 1-Contacting-mediated Activation of Wnt-beta-catenin Pathway

Role of Platelet Activation in the Development and Metastasis of Solid Tumors

Platelets and cancer: a casual or causal relationship: revisited

The dynamic role of platelets in cancer progression and their therapeutic implications

Platelets in the Tumor Microenvironment and Their Biological Effects on Cancer Hallmarks

Emerging roles of platelets in cancer biology and their potential as therapeutic targets

Roles of Platelets in Tumor Invasion and Metastasis: A Review.

Roles of Platelets in Tumor Progression

Role of platelets and platelet receptors in cancer metastasis

Activated platelets facilitate hematogenous metastasis of breast cancer by modulating the PDGFR-β/COX-2 axis

Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy